TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
182 hedge funds and large institutions have $387M invested in Tvardi Therapeutics, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 71 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
182
Holders Change
+2
Holders Change %
+1.11%
% of All Funds
2.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
71
Closed
23
Calls
$4.35M
Puts
$1.35M
Net Calls
+$3M
Net Calls Change
+$306K
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$6.07M |
| 2 |
PA
Pinnacle Associates
New York
|
+$4.35M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$3.64M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.17M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.57M |
